AVNS
Avanos Medical, Inc. (NYSE)
Healthcare — Medical Devices
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Price History
Fundamentals
| Market Cap | $1.17B |
| P/E Ratio (TTM) | - |
| Forward P/E | 19.90 |
| EPS (TTM) | $-1.60 |
| Dividend Yield | - |
| Profit Margin | -10.39% |
| Revenue Growth | 8.80% |
| ROE | -9.18% |
| Debt/Equity | 17.70 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NYSE |
Technical Indicators
| RSI (14) | 34.7 |
| Beta | 1.58 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $25.49 |
| 52-Week Low | $9.30 |
| 50-Day Avg | $24.81 |
| 200-Day Avg | $15.74 |
| Avg Volume | $1.59M |
| Volume | 310.0K |
Performance Analysis
NEUTRALAVNS presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jun 30, 2026 21:08 UTC
Back to Screener Export Report